
浏览全部资源
扫码关注微信
1.山东中医药大学,济南 250355
2.山东第一医科大学 附属省立医院,济南 250021
3.山东中医药大学 第二附属医院,济南 250001
周雨禾,在读硕士,从事中西医结合诊治不孕不育及妇科杂病研究,E-mail:Z13869156371@163.com
* 马宏博,博士,主任医师,博士生导师,从事中西医结合诊治不孕不育及妇科杂病研究,E-mail:dellamhb@sina.com
收稿日期:2021-02-24,
网络出版日期:2021-03-26,
纸质出版日期:2021-08-20
移动端阅览
周雨禾,刘婷,马宏博.黄连温胆汤合少腹逐瘀汤加减治疗痰瘀互结证多囊卵巢综合征致排卵障碍的临床疗效[J].中国实验方剂学杂志,2021,27(16):96-101.
ZHOU Yu-he,LIU Ting,MA Hong-bo.Efficacy of Modified Huanglian Wendantang and Shaofu Zhuyutang Against Ovulation Disorder in Combined Phlegm and Stasis-Induced Polycystic Ovary Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(16):96-101.
周雨禾,刘婷,马宏博.黄连温胆汤合少腹逐瘀汤加减治疗痰瘀互结证多囊卵巢综合征致排卵障碍的临床疗效[J].中国实验方剂学杂志,2021,27(16):96-101. DOI: 10.13422/j.cnki.syfjx.20210732.
ZHOU Yu-he,LIU Ting,MA Hong-bo.Efficacy of Modified Huanglian Wendantang and Shaofu Zhuyutang Against Ovulation Disorder in Combined Phlegm and Stasis-Induced Polycystic Ovary Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(16):96-101. DOI: 10.13422/j.cnki.syfjx.20210732.
目的
2
观察黄连温胆汤合少腹逐瘀汤加减治疗痰瘀互结证多囊卵巢综合征(PCOS)致排卵障碍的临床疗效及对慢性炎症状态的影响。
方法
2
将100例患者按随机数字表法分为对照组和观察组各50例。所有患者给予生活方式干预,并口服枸橼酸氯米芬(CC)胶囊促排卵。对照组口服桂枝茯苓丸,6 g/次,2次/d;观察组黄连温胆汤合少腹逐瘀汤加减内服,1剂/d。两组疗程均为6个月经周期;监测排卵情况,测量治疗前后子宫内膜厚度,A型子宫内膜比例、子宫动脉血流的搏动指数(PI)和阻力指数(RI);检测治疗前后空腹血糖(FBG),空腹胰岛素(FINS),黄体生成素(LH),卵泡刺激素(FSH),血清睾酮(T),雌二醇(E
2
)和硫酸脱氢表雄酮(DHEAS)水平,计算胰岛素抵抗指数(HOMA-IR);评价治疗前后卵巢体积和痰瘀互结证积分;检测治疗前后肿瘤坏死因子-
α
(TNF-
α
),超敏C-反应蛋白(hs-CRP),脂联素(APN)和白细胞介素-6(IL-6)水平。
结果
2
观察组临床疗效总有效率为(44/47)93.62%,高于对照组的(36/46)78.26%(
χ
2
=4.802,
P
<
0.05);观察组排卵率为(199/264)75.38%,高于对照组的(173/272)63.60%(
χ
2
=8.714,
P
<
0.01),观察组临床妊娠率(11/47)23.40%,高于对照组的(5/46)10.87%,但差异无统计学意义(
χ
2
=2.564,
P
>
0.05);观察组PI和RI均低于对照组(
P
<
0.01),子宫内膜厚度,A型内膜比例高于对照组(
P
<
0.01);观察组LH,T和DHEAS水平均低于对照组(
P
<
0.01),E
2
和FSH水平均高于对照组(
P
<
0.01);观察组双侧卵巢体积和痰瘀互结证积分均低于对照组(
P
<
0.01);观察组FINS,FPG和HOMA-IR均低于对照组(
P
<
0.01);观察组TNF-
α
,hs-CRP和IL-6水平均低于对照组(
P
<
0.01),APN水平高于对照组(
P
<
0.01)。
结论
2
在CC治疗的基础上,黄连温胆汤合少腹逐瘀汤加减内服可改善PCOS痰瘀互结证患者的排卵障碍,并能调节胰岛素抵抗(IR)和慢性炎症状态,为临床妊娠创造了条件,值得进一步的研究。
Objective
2
To observe the clinical efficacy of modified Huanglian Wendantang and Shaofu Zhuyutang in the treatment of ovulation disorder in patients with polycystic ovary syndrome (PCOS) due to the combined phlegm and stasis-induced and its influence on chronic inflammation.
Method
2
According to the random number table, 100 patients were divided into a control group (50 cases) and an observation group (50 cases). Apart from lifestyle intervention and oral administration of clomiphene citrate (CC) capsules to induce ovulation, patients in the control group further received Guizhi Fulingwan, 6 g/time, 2 times/day, while those in the observation group were treated with the modified Huanglian Wendantang and Shaofu Zhuyutang, 1 dose/day, for six menstrual cycles. The ovulation, endometrial thickness, proportion of type A endometrium, as well as the pulsatility index (PI) and resistance index (RI) of uterine artery were monitored before and after treatment. The fasting blood glucose (FBG), fasting insulin (FINS), luteinizing hormone (LH), follicle stimulating hormone (FSH), serum testosterone (T), estradiol (E
2
), dehydroepiandrosterone sulfate (DHEAS), tumor necrosis factor-
α
(TNF-
α
), high-sensitivity C-reactive protein (hs-CRP), adiponectin (APN), and interleukin-6 (IL-6) levels before and after treatment were detected, followed by the calculation of homeostasis model assessment-insulin resistance (HOMA-IR) value and the evaluation of ovarian volume and combined phlegm and stasis-induced syndrome score.
Result
2
The overall response rate of the observation group was (44/47) 93.62%, which was higher than (36/46) 78.26% of the control group (
χ
2
=4.802,
P
<
0.05). The ovulation rate in the observation group was (199/264) 75.38%, higher than (173/272) 63.60% in the control group (
χ
2
=8.714,
P
<
0.01). The clinical pregnancy rate of the observation group was (11/47) 23.40%, higher than (5/46) 10.87% of the control group, but the difference was not statistically significant (
χ
2
=2.564,
P
>
0.05). Compared with the control group, the observation group exhibited reduced PI, RI, LH, T, DHEAS, FINS, FPG, HOMA-IR, TNF-
α
, hs-CRP, and IL-6 (
P
<
0.01), but elevated E
2
, FSH, and APN (
P
<
0.01). Besides, the bilateral ovarian volume and combined phlegm and stasis-induced syndrome score of the observation group were smaller than those of the control group (
P
<
0.01), while the endometrial thickness and proportion of type A endometrium were higher (
P
<
0.01).
Conclusion
2
On the basis of CC treatment, the modified Huanglian Wendantang and Shaofu Zhuyutang alleviates the ovulation disorder in PCOS patients of combined phlegm and stasis-induced syndrome and regulates IR and chronic inflammation, thus creating a favorable condition for clinical pregnancy, which is worthy of further research.
袁莹莹 , 赵君利 . 多囊卵巢综合征流行病学特点 [J]. 中国实用妇科与产科杂志 , 2019 , 35 ( 3 ): 261 - 264 .
邢利威 , 赖明星 , 赵冬 , 等 . 针灸对多囊卵巢综合征排卵障碍研究特点分析 [J]. 辽宁中医杂志 , 2019 , 46 ( 12 ): 2632 - 2636 .
杨帆 , 常惠 , 贾丽妍 , 等 . 中医治疗多囊卵巢综合征进展 [J]. 辽宁中医杂志 , 2020 , 47 ( 11 ): 206 - 209 .
原博超 , 马堃 , 张辰晖 , 等 . 补肾活血中药治疗多囊卵巢综合征导致不孕症的Meta分析 [J]. 中国中药杂志 , 2019 , 44 ( 6 ): 1080 - 1086 .
张晓金 , 归绥琪 , 黄书慧 , 等 . 从“痰瘀”论治多囊卵巢综合征不孕临床研究 [J]. 中华中医药杂志 , 2016 , 31 ( 2 ): 415 - 419 .
刘莉 , 李卫忠 , 邹国良 , 等 . 黄连温胆汤治疗代谢综合征研究进展 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 17 ): 190 - 196 .
曹俊红 . 西药联合少腹逐瘀汤治疗多囊卵巢综合征致不孕症62例临床观察 [J]. 中国民族民间医药 , 2019 , 28 ( 10 ): 116 - 119 .
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J]. Fertil Steril , 2004 , 81 ( 1 ): 19 - 25 .
中华中医药学会 . 中医妇科常见病诊疗指南 [M]. 北京 : 中国中医药出版社 , 2012 : 104 - 108 .
中华医学会妇产科学分会内分泌学组及指南专家组 . 多囊卵巢综合征中国诊疗指南 [J]. 中华妇产科杂志 , 2018 , 53 ( 1 ): 2 - 6 .
唐培培 , 谈勇 . 多囊卵巢综合征中医证型分布规律及性激素水平、糖代谢特点 [J]. 中国中西医结合杂志 , 2016 , 36 ( 7 ): 801 - 805 .
国家中医管理局医政司 . 24个专业105个病种中医诊疗方案(试行版) [M]. 北京 : 国家中医药管理局医政司 , 2011 : 533 - 536 .
常久 , 李晓君 . 对多囊卵巢综合征与痰湿、瘀血致病的关联性探讨 [J]. 中国中医基础医学杂志 , 2015 , 21 ( 9 ): 1128 - 1130,1145 .
刘敏 , 朱鸿秋 , 李印 , 等 . 桂枝茯苓丸调节PI3K/Akt/mTOR通路对PCOS-IR大鼠排卵障碍的影响 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 6 ): 7 - 14 .
寇丽辉 , 侯丽辉 , 郝松莉 , 等 . 多囊卵巢综合征1500例患者临床及内分泌代谢特征分析 [J]. 中华中医药杂志 , 2020 , 35 ( 6 ): 2842 - 2847 .
张燕 , 康卉娴 , 包俊华 . 血清炎症细胞因子与多囊卵巢综合征不孕症患者IVF-ET助孕妊娠结局的相关性分析 [J]. 中国妇幼保健 , 2021 , 36 ( 1 ): 113 - 117 .
姜梅芳 , 朱晶瑜 , 陈朋 , 等 . 穴位埋线联合中药治疗对多囊卵巢综合征患者血清CRP,TNF- α ,IL-6水平影响的临床研究 [J]. 广州中医药大学学报 , 2019 , 36 ( 7 ): 998 - 1002 .
李天鹤 , 刘瑞霞 , 岳文涛 , 等 . 脂联素在多囊卵巢综合征中作用机制的进展 [J]. 生殖医学杂志 , 2019 , 28 ( 11 ): 1371 - 1375 .
0
浏览量
21
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621